Related references
Note: Only part of the references are listed.Mechanistic insights into monomer level prevention of amyloid aggregation of lysozyme by glycyrrhizic acid
Shivani A. Muthu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)
Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics
Vishal Singh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)
An inclusive study of deleterious missense PAX9 variants using user-friendly tools reveals structural, functional alterations, as well as potential therapeutic targets.
Prashant Ranjan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)
Vibrational spectroscopic, quantum computational (DFT), reactivity (ELF, LOL and Fukui), molecular docking studies and molecular dynamic simulation on (6-methoxy-2-oxo-2H-chromen-4-yl) methyl morpholine-4-carbodithioate
V. S. Jeba Reeda et al.
JOURNAL OF MOLECULAR LIQUIDS (2023)
Molecular docking and molecular dynamics simulation study on the toxicity mechanism of bongkrekic acid
Hongmei Li et al.
TOXICON (2023)
Therapeutic potential of Indian medicinal plants against Leishmania donovani: a review
Nibedita Pyne et al.
PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY (2023)
An Update on Natural Antileishmanial Treatment Options from Plants, Fungi and Algae
Waleed S. Koko et al.
CHEMISTRY & BIODIVERSITY (2022)
Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties
Mohnad Abdalla et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2022)
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview
Silvia Salerno et al.
BIOMEDICINES (2022)
Modulating mitofusins to control mitochondrial function and signaling
Emmanouil Zacharioudakis et al.
NATURE COMMUNICATIONS (2022)
DNA topoisomerases in the unicellular protozoan parasites: Unwinding the mystery
Swati Lamba et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Non-food bioactive forest product liriodenine: Sources, chemistry, and bioactivities
Xiaobo Huang et al.
INDUSTRIAL CROPS AND PRODUCTS (2022)
Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics
Sara Scarpini et al.
MICROORGANISMS (2022)
Anticancer Properties of Eugenol: A Review
Ali T. Zari et al.
MOLECULES (2021)
Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
Abbas Khan et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease
Anuj Gahlawat et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Closing the DNA replication cycle: from simple circular molecules to supercoiled and knotted DNA catenanes
Jorge B. Schvartzman et al.
NUCLEIC ACIDS RESEARCH (2019)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase
Sourav Saha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Computational protein-ligand docking and virtual drug screening with the AutoDock suite
Stefano Forli et al.
NATURE PROTOCOLS (2016)
Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors
Rajinikanth Mamidala et al.
SCIENTIFIC REPORTS (2016)
Natural product based leads to fight against leishmaniasis
Nisha Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo
Sourav Saha et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice
Sayan Chowdhury et al.
EMBO MOLECULAR MEDICINE (2012)
Targeting Intestinal Transporters for Optimizing Oral Drug Absorption
Manthena V. Varma et al.
CURRENT DRUG METABOLISM (2011)
Vaccine candidates for leishmaniasis: A review
Rajeev Nagill et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Yves Pommier
CHEMICAL REVIEWS (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3′-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme
Amit Roy et al.
BIOCHEMICAL JOURNAL (2008)
The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA
DR Davies et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I
BB Das et al.
NUCLEIC ACIDS RESEARCH (2006)
Leishmania donovani: Differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays
V Jean-Moreno et al.
EXPERIMENTAL PARASITOLOGY (2006)
Reconstitution and functional characterization of the unusual bi-subunit type I DNA topoisomerase from Leishmania donovani
BB Das et al.
FEBS LETTERS (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
A novel active DNA topoisomerase I in Leishmania donovani
H Villa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Increasing the precision of comparative models with YASARA NOVA - a self-parameterizing force field
E Krieger et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)
Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis
B Mittra et al.
MOLECULAR MEDICINE (2000)
Share Paper
